Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00222924 · ClinicalTrials.gov registry record · NA
Mitochondrial Impairment in Muscle Insulin Resistance
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
NCT00222924 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 49 participants.
The verdict
NCT00222924, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
Study Summary
This investigation is being carried out to learn more about research findings from a study that was completed last year. Those findings revealed that within the skeletal muscle cells of individuals with type 2 diabetes, there was often damage to the mitochondria (the muscle cell's power source or the machinery of the muscle cell that produces energy). In individuals with type 2 diabetes, the liver continues to release sugar even when sugar levels are normal; the pancreas is not able to produce and release insulin normally; and the muscle and fat cells no longer respond as effectively to insulin. These defects lead to an abnormal rise of sugar in the blood. In this study, we want both to look more closely at the mitochondria and see if there is potential for improving mitochondrial functioning (improving the machinery of the muscle cell that produces energy) and reversing mitochondrial damage through a weight loss or a combined exercise/weight loss program. The program you get assigned to will be determined by a process called randomization (like a flip of a coin).
Interventions
- BEHAVIORAL weight loss/ exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2003-12 |
| Est. Completion | 2006-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00222924
The ClinicalTrials.gov registry entry for NCT00222924 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which weight loss/ exercise is the first listed.
NCT00222924 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00222924 about?
NCT00222924 is a clinical study titled "Mitochondrial Impairment in Muscle Insulin Resistance". This investigation is being carried out to learn more about research findings from a study that was completed last year. Those findings revealed that within the skeletal muscle cells of individuals with type 2 diabetes, there was often damage to the mitochondria (the muscle cell's power source or th...
What is the current status of trial NCT00222924?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2003-12. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00222924?
The interventions under investigation include: weight loss/ exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT00222924?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.